Mounjaro vs Ozempic for Weight Loss: Which Works Better in 2026?

Available online. Shipped directly to your door anywhere in the US.

Mounjaro vs Ozempic: the two biggest names in weight loss

If you are researching GLP-1 medications for weight loss, you have almost certainly seen two names pop up: Mounjaro and Ozempic. Mounjaro contains tirzepatide, a dual GIP/GLP-1 receptor agonist. Ozempic contains semaglutide, a single GLP-1 receptor agonist. Both were originally developed for type 2 diabetes, but both are widely prescribed off-label for obesity because of their powerful appetite-suppressing effects.

The question is no longer whether these medications work. It is which one works better for your body, goals, and budget. This guide compares Mounjaro vs Ozempic for weight loss using clinical evidence, real-world factors, side effect profiles, and 2026 pricing.

How do Mounjaro and Ozempic work?

Both medications mimic natural gut hormones that regulate appetite and blood sugar. However, tirzepatide has an extra mechanism that semaglutide does not.

• Ozempic (semaglutide): Activates GLP-1 receptors. This slows stomach emptying, reduces hunger signals in the brain, and helps regulate blood glucose.
• Mounjaro (tirzepatide): Activates both GLP-1 and GIP receptors. GIP may enhance insulin secretion and fat metabolism, possibly giving tirzepatide a stronger metabolic effect.

Because Mounjaro targets two hormone pathways instead of one, it has generally produced larger weight reductions in head-to-head clinical trials.

Clinical results: Mounjaro vs Ozempic for weight loss

Head-to-head data gives Mounjaro a measurable edge for weight loss. In the SURPASS-2 trial, tirzepatide produced average weight loss of roughly 8 to 12 percent of body weight at higher doses, compared with about 6.7 percent with semaglutide 1 mg.

The SURMOUNT-1 trial, which studied tirzepatide specifically in people with obesity, showed average weight loss of approximately:

• 15 percent at 5 mg
• 19.5 percent at 10 mg
• 20.9 percent at 15 mg

For semaglutide, the STEP-1 trial showed about 14.9 percent average weight loss at 2.4 mg weekly. That is still excellent, but the highest tirzepatide doses produced larger reductions on average.

Individual results vary. Some people respond better to semaglutide than tirzepatide. Genetics, starting weight, diet, activity, and adherence all play a role. Still, if you are choosing purely based on average clinical effect, Mounjaro has the higher numbers.

Dosing and administration

Both medications are once-weekly injections. Ozempic is typically titrated from 0.25 mg to 1 mg or 2 mg. Wegovy, the weight-loss brand of semaglutide, goes up to 2.4 mg weekly. Mounjaro starts at 2.5 mg and increases through 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg.

Tirzepatide has more dose steps, which can help some patients tolerate side effects while still reaching an effective maintenance dose. For a complete semaglutide dosing schedule, see our semaglutide dosage guide.

Side effects: nausea, vomiting, and GI issues

Both medications cause similar gastrointestinal side effects. The most common are nausea, diarrhea, vomiting, constipation, and abdominal discomfort. These side effects usually peak during dose increases and improve over time.

Because tirzepatide is generally more potent, some patients experience slightly more nausea at higher doses. However, both drugs are usually well tolerated when doses are increased slowly and patients follow dietary guidance.

Serious but rare risks include pancreatitis, gallbladder disease, thyroid C-cell tumors in animal studies, and low blood sugar when combined with other diabetes medications. A licensed clinician can help you weigh these risks based on your medical history.

Cost and insurance coverage in 2026

Without insurance, Ozempic and Mounjaro both cost roughly $1,000 to $1,300 per month at retail pharmacies. Wegovy is in a similar range. Insurance coverage varies widely. Some plans cover them for type 2 diabetes but not for weight loss.

If your insurance does not cover the brand-name version, options include:

• Manufacturer savings cards (when eligible)
• Compounded semaglutide or compounded tirzepatide through a licensed telehealth pharmacy
• US telehealth weight-loss programs that bundle medication, consultation, and delivery

For a full breakdown, read our guide on the cheapest GLP-1 for weight loss.

Who should choose Mounjaro?

Mounjaro may be a better fit if:

• You want the highest average weight-loss results
• You have significant insulin resistance or prediabetes
• You tolerate dose increases well
• You prefer a medication with dual GIP/GLP-1 action

Who should choose Ozempic?

Ozempic may be a better fit if:

• You want a well-established medication with years of safety data
• You have type 2 diabetes and need blood sugar control
• You experienced side effects with tirzepatide
• Your insurance covers Ozempic more easily than Mounjaro

Mounjaro vs Ozempic: quick comparison table

Can you switch from Ozempic to Mounjaro?

Yes, many patients switch between these medications under medical supervision. Common reasons include better weight loss on tirzepatide, fewer side effects on semaglutide, or insurance and supply issues. Do not switch on your own. A clinician will usually start you on a low dose of the new medication to minimize side effects.

How to get Mounjaro or Ozempic online

You can get either medication through a licensed US telehealth weight-loss program. The typical process is:

1. Complete an online health questionnaire
2. A licensed provider reviews your BMI, medical history, and goals
3. If approved, the medication is prescribed and shipped to your home
4. Ongoing follow-up helps adjust your dose and manage side effects

This avoids pharmacy shortages and insurance paperwork for many patients. For more details, see our guide on how to get prescribed GLP-1 online.

Frequently asked questions

Is Mounjaro better than Ozempic for weight loss?

On average, clinical trials show greater weight loss with tirzepatide (Mounjaro) than with semaglutide (Ozempic). However, individual results vary, and some people do better on one medication than the other.

Can I get Mounjaro prescribed for weight loss?

Mounjaro is FDA-approved for type 2 diabetes, but providers may prescribe it off-label for weight loss when clinically appropriate. Telehealth weight-loss programs can evaluate your eligibility online.

Does insurance cover Mounjaro or Ozempic for weight loss?

Coverage varies. Some plans cover these drugs for diabetes but not for obesity. Many telehealth programs offer cash-pay options, compounded alternatives, or savings cards.

What is the strongest GLP-1 medication for weight loss?

Currently, tirzepatide (Mounjaro/Zepbound) has shown the largest average weight reduction in clinical trials. Zepbound is the FDA-approved weight-loss brand of tirzepatide.

How fast will I lose weight on Mounjaro or Ozempic?

Most patients begin losing weight within the first 2 to 4 weeks, with faster progress after the dose reaches the therapeutic range. Significant results are usually seen by month three and beyond.

Conclusion

Both Mounjaro and Ozempic are effective GLP-1 medications for weight loss. If average clinical effect is your main priority, Mounjaro (tirzepatide) has the stronger data. If you prefer a medication with a longer track record or better insurance coverage, Ozempic (semaglutide) remains an excellent choice. The best medication is the one that fits your health profile, side effect tolerance, and budget — and that decision should be made with a licensed clinician.

Ready to compare options? Check your eligibility for a US telehealth GLP-1 program and get your medication shipped directly to your door.